Can monocytes predict prognosis of idiopathic pulmonary fibrosis?

Michael Kreuter, Toby M Maher

Abstract readComment

In one paragraph

Article in The Lancet. Respiratory medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it

0cells of the map it votes in

7citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

Particles exposures and sarcoidosis.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2025
Article
Integrative Analyses of Single-Cell RNA-Sequencing and Bulk RNA-Sequencing Reveal Prognostic Markers of Peripheral Blood Mononuclear Cells in Patients with Cardiogenic Shock Receiving Venous-Arterial Extracorporeal Membrane Oxygenation Support Collected before Venous-Arterial Extracorporeal Membrane Oxygenation Establishment.ACS omega · 2025
Article
Associations of Monocyte Count and Other Immune Cell Types with Interstitial Lung Abnormalities.American journal of respiratory and critical care medicine · 2022
Article
Identification of diagnostic gene biomarkers related to immune infiltration in patients with idiopathic pulmonary fibrosis based on bioinformatics strategies.Frontiers in medicine · 2022
Article
Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis.American journal of respiratory and critical care medicine · 2021
Article
Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis.Respiratory research · 2021
Observational
Airway Redox Homeostasis and Inflammation Gone Awry: From Molecular Pathogenesis to Emerging Therapeutics in Respiratory Pathology.International journal of molecular sciences · 2020
Review

4 · The record

Corrections and comments

Comment on
Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study.2019

5 · Who and what money

Authors and funding

2 authors.

Michael KreuterCenter for interstitial and rare lung diseases, Thoraxklinik, University of Heidelberg and German Center for Lung Research (DZL), 69126 Heidelberg, Germany. Electronic address: kreuter@uni-heidelberg.de.

Toby M MaherNational Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton Hospital, London, UK; Fibrosis Research Group, National Heart and Lung Institute, Imperial College London, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Idiopathic Pulmonary FibrosisMonocytesBiomarkersCohort StudiesHumansPrognosisRetrospective StudiesBiomarkers

Identifiers

PMID30935880

DOI10.1016/S2213-2600(19)30050-5

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.